Abivax - ADR

Abivax - ADR

ABVX

Get informed when a big investor buys or sells

+ Follow
Market Cap$8.32B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Abivax - ADRAbivax - ADR-20.2--90%-0.1
$142.60

Target Price by Analysts

28.4% upsideAbivax Target Price DetailsTarget Price
$7.84

Current Fair Value

92.9% downside

Overvalued by 92.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$8.32 Billion
Enterprise Value$7.84 Billion
Dividend Yield$- (-)
Earnings per Share$-4.65
Beta-0.23
Outstanding Shares69,527,315

Return

Return on Equity-90.32%ROE
Return on Assets-70.36%
Return on Invested Capital-62.80%

Valuation & Multiples

P/E Ratio-20.17P/E Ratio
PEG-5.46PEG
Price to Sales-Price to Sales
Price to Book Ratio18.51Price to Book Ratio
Enterprise Value to Revenue1452.78
Enterprise Value to EBIT-23.96
Enterprise Value to Net Income-20
Total Debt to Enterprise0
Debt to Equity0.07Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
June 1, 2026
EPS Estimate
$-0.92
Average shareholder expectation
Revenue Estimate
$602,961
Average shareholder expectation

Next Earnings Call

Expected Date
September 14, 2026
EPS Estimate
$-0.96
Average shareholder expectation
Revenue Estimate
$778,451
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5354 6.24%
Total Calls7,594,118 310.50%
Total Puts4,065,944 267.67%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %79.02% 7.06%
Total Invested$7.18B 29.83%
Investors Holding366 80.00%

ESG Score

No data

About Abivax